MUSANI V[au] - Search Results

Year	Number of Results
2001	1
2003	1
2004	2
2006	1
2007	1
2008	2
2009	6
2010	2
2011	2
2012	5
2013	2
2014	1
2015	2
2017	3
2018	3
2019	3
2020	1
2021	1
2022	0

1

SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells.

Trnski D, Sabol M, Tomić S, Štefanac I, Mrčela M, Musani V, Rinčić N, Kurtović M, Petrić T, Levanat S, Ozretić P. Trnski D, et al. Among authors: musani v. Sci Rep. 2021 Jul 21;11(1):14880. doi: 10.1038/s41598-021-93971-6. Sci Rep. 2021. PMID: 34290270 Free PMC article.

2

Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors.

Levanat S, Sabol M, Musani V, Ozretic P, Trnski D. Levanat S, et al. Among authors: musani v. Curr Pharm Des. 2017;23(1):73-94. doi: 10.2174/1381612822666161006154705. Curr Pharm Des. 2017. PMID: 27719639 Review.

3

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets.

Sabol M, Trnski D, Musani V, Ozretić P, Levanat S. Sabol M, et al. Among authors: musani v. Int J Mol Sci. 2018 Aug 29;19(9):2562. doi: 10.3390/ijms19092562. Int J Mol Sci. 2018. PMID: 30158435 Free PMC article. Review.

4

Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer.

Trnski D, Gregorić M, Levanat S, Ozretić P, Rinčić N, Vidaković TM, Kalafatić D, Maurac I, Orešković S, Sabol M, Musani V. Trnski D, et al. Among authors: musani v. Cells. 2019 Feb 6;8(2):128. doi: 10.3390/cells8020128. Cells. 2019. PMID: 30736319 Free PMC article.

5

Gorlin syndrome patient with large deletion in 9q22.32-q22.33 detected by quantitative multiplex fluorescent PCR.

Musani V, Cretnik M, Situm M, Basta-Juzbasic A, Levanat S. Musani V, et al. Dermatology. 2009;219(2):111-8. doi: 10.1159/000219247. Epub 2009 May 14. Dermatology. 2009. PMID: 19439922 Review.

6

GANT61 and Lithium Chloride Inhibit the Growth of Head and Neck Cancer Cell Lines Through the Regulation of GLI3 Processing by GSK3β.

Zubčić V, Rinčić N, Kurtović M, Trnski D, Musani V, Ozretić P, Levanat S, Leović D, Sabol M. Zubčić V, et al. Among authors: musani v. Int J Mol Sci. 2020 Sep 3;21(17):6410. doi: 10.3390/ijms21176410. Int J Mol Sci. 2020. PMID: 32899202 Free PMC article.

7

Clinical utility gene card for: Gorlin syndrome--update 2013.

Lo Muzio L, Pastorino L, Levanat S, Musani V, Situm M, Ponti G, Bianchi Scarra G. Lo Muzio L, et al. Among authors: musani v. Eur J Hum Genet. 2013 Oct;21(10). doi: 10.1038/ejhg.2012.299. Epub 2013 Jan 30. Eur J Hum Genet. 2013. PMID: 23361221 Free PMC article. No abstract available.

8

Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines.

Ozretić P, Hanžić N, Proust B, Sabol M, Trnski D, Radić M, Musani V, Ciribilli Y, Milas I, Puljiz Z, Bosnar MH, Levanat S, Slade N. Ozretić P, et al. Among authors: musani v. Sci Rep. 2019 Aug 28;9(1):12470. doi: 10.1038/s41598-019-48882-y. Sci Rep. 2019. PMID: 31462745 Free PMC article.

9

Polymorphisms in Survivin (BIRC5 Gene) Are Associated with Age of Onset in Breast Cancer Patients.

Sušac I, Ozretić P, Gregorić M, Levačić Cvok M, Sabol M, Levanat S, Trnski D, Eljuga D, Seiwerth S, Aralica G, Stanec M, Musani V. Sušac I, et al. Among authors: musani v. J Oncol. 2019 Jul 28;2019:3483192. doi: 10.1155/2019/3483192. eCollection 2019. J Oncol. 2019. PMID: 31467536 Free PMC article.

10

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.

Cacev T, Zapletal E, Musani V, Rako I, Loncar B, Aralica G, Kapitanovic S. Cacev T, et al. Among authors: musani v. Anticancer Res. 2018 May;38(5):2841-2848. doi: 10.21873/anticanres.12529. Anticancer Res. 2018. PMID: 29715107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results